Medial Temporal Atrophy as a Magnetic Resonance Imaging Marker for Alzheimer's Disease

L. Barclay,C. Linden,R. Murtagh
DOI: https://doi.org/10.1111/jon199223131
1992-07-01
Journal of Neuroimaging
Abstract:Medial temporal lobe atrophy (MTLA) on brain magnetic resonance imaging (MRI) may help differentiate Alzheimer's disease (AD) from multiinfarct dementia (MID) and other dementias. MTLA was seen in 6 of 11 patients with clinically diagnosed AD, 16 of 20 with mixed dementia (with both AD and MID), 1 of 5 with psychiatric disease, and in none of 32 with MID or 8 with other dementias (p < 0.0001 ). Increased patchy periventricular signal, or “unidentified bright objects” were seen in 2 of 11 patients with AD, 10 of 20 patients with AD and MID, and 26 of 32 patients with MID. A larger series with autopsy correlation may verify that MTLA is a reasonably specific marker for AD, and unidentified bright objects are a sensitive, but not specific, marker for vascular dementias.
What problem does this paper attempt to address?